BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2624613)

  • 1. Vinpocetine pharmacokinetics in elderly subjects.
    Grandt R; Beitinger H; Schaltenbrand R; Braun W
    Arzneimittelforschung; 1989 Dec; 39(12):1599-602. PubMed ID: 2624613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of apovincaminic acid in dogs.
    Vereczkey L; Pudleiner P
    Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinpocetine therapy does not change imipramine pharmacokinetics in man.
    Hitzenberger G; Schmid R; Braun W; Grandt R
    Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):99-104. PubMed ID: 2318551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the possible influence of the absorption of vinpocetine with concomitant application of magnesium-aluminium-hydroxide gel.
    Lohmann A; Grobara P; Dingler E
    Arzneimittelforschung; 1991 Nov; 41(11):1164-7. PubMed ID: 1810262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of age on the pharmacokinetics of nimodipine.
    Mück W; Breuel HP; Kuhlmann J
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):293-8. PubMed ID: 8832305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of vinpocetine in humans.
    Vereczkey L; Czira G; Tamás J; Szentirmay Z; Botár Z; Szporny L
    Arzneimittelforschung; 1979; 29(6):957-60. PubMed ID: 582791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
    Miskolczi P; Kozma K; Polgár M; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of rizatriptan in healthy elderly subjects.
    Musson DG; Birk KL; Panebianco DL; Gagliano KD; Rogers JD; Goldberg MR
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):447-52. PubMed ID: 11680669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
    Hitzenberger G; Sommer W; Grandt R
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.
    Miskolczi P; Vereczkey L; Szalay L; Göndöc C
    Eur J Clin Pharmacol; 1987; 33(2):185-9. PubMed ID: 3691609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic metabolism of vinpocetine in the rat.
    Vereczkey L; Szentirmay Z; Szporny L
    Arzneimittelforschung; 1979; 29(6):953-6. PubMed ID: 582790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and disposition of vinpocetine in rats].
    Yao JH; Su CY; Chu XY
    Yao Xue Xue Bao; 1994; 29(2):81-5. PubMed ID: 8042515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absolute oral bioavailability of dapsone in dogs and humans.
    Pieters FA; Zuidema J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):396-400. PubMed ID: 3623744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
    Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects.
    Kovarik JM; Hartmann S; Bartlett M; Riviere GJ; Neddermann D; Wang Y; Port A; Schmouder RL
    Biopharm Drug Dispos; 2007 Mar; 28(2):97-104. PubMed ID: 17230596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of vinpocetine (Cavinton) in dog.
    Polgár M; Vereczkey L
    Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
    Lefebvre RA; Rosseel MT; Bernheim J
    Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.